Pages that link to "Q42519780"

The following pages link to Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice (Q42519780):

Displaying 34 items.

• Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling (Q24319108) (← links)
• Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone (Q28508968) (← links)
• Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions (Q28580087) (← links)
• The spatiotemporal role of COX-2 in osteogenic and chondrogenic differentiation of periosteum-derived mesenchymal progenitors in fracture repair (Q33837902) (← links)
• TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women (Q34126306) (← links)
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress (Q34200165) (← links)
• Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice (Q34667102) (← links)
• Molecular mechanisms underlying osteoclast formation and activation (Q35157702) (← links)
• Mechanical loading reduces inflammation-induced human osteocyte-to-osteoclast communication. (Q35817284) (← links)
• Rheumatic diseases: the effects of inflammation on bone (Q36324975) (← links)
• The protocol for the isolation and cryopreservation of osteoclast precursors from mouse bone marrow and spleen (Q36422055) (← links)
• Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis (Q36518539) (← links)
• Association analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women. (Q36928773) (← links)
• PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis (Q37345108) (← links)
• Pathophysiology of cyclooxygenase inhibition in animal models (Q37398476) (← links)
• Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors (Q37863768) (← links)
• Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis (Q37644800) (← links)
• Host‐derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis (Q37842635) (← links)
• PGE2 Receptor Subtype 1 (EP1) Regulates Mesenchymal Stromal Cell Osteogenic Differentiation by Modulating Cellular Energy Metabolism. (Q38818869) (← links)
• Prostaglandin E2 receptor EP4-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation (Q39305262) (← links)
• Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells (Q39326342) (← links)
• Macrophage response to high number of titanium particles is cytotoxic and COX‐2 mediated and it is not affected by the particle's endotoxin content or the cleaning treatment (Q39466922) (← links)
• Oral Administration of Prostaglandin E2‐Specific Receptor 4 Antagonist Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis in Rat Periodontal Tissue (Q39475508) (← links)
• PGE2 activates cementoclastogenesis by cementoblasts via EP4. (Q40077128) (← links)
• COX-2 involvement in breast cancer metastasis to bone (Q40184738) (← links)
• Effects of endogenous and exogenous prostaglandin E2 on the proliferation and differentiation of a mouse cementoblast cell line (OCCM-30). (Q40185617) (← links)
• In vitro biocompatibility of a new titanium-29niobium-13tantalum-4.6zirconium alloy with osteoblast-like MG63 cells. (Q40454228) (← links)
• A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro (Q41017658) (← links)
• Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures (Q42671749) (← links)
• Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures (Q44601889) (← links)
• Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells (Q44833032) (← links)
• Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. (Q53581241) (← links)
• Amelogenin Peptide Extract Increases Differentiation and Angiogenic and Local Factor Production and Inhibits Apoptosis in Human Osteoblasts (Q58994796) (← links)
• Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: An in vitro study (Q83820568) (← links)